New White Paper: The Value of Generic Contrast Utilization in Imaging

Sponsored by Fresenius Kabi

A new white paper from Fresenius Kabi examines clinical, operational, and financial considerations related to FDA-approved generic contrast agents for MRI and CT imaging. Topics include supply diversification, implementation strategies, and quality monitoring. 

Download the White Paper

Contact your Fresenius Kabi representative or visit GenericContrastAgents.com for more information.